Do we currently have biomarkers in the setting of RA that will predict patient response to the range of agents -- including inhibitors of IL-6, TNF and other signaling cytokines -- currently used for RA?

Do we currently have biomarkers in the setting of RA that will predict patient response to the range of agents -- including inhibitors of IL-6, TNF and other signaling cytokines -- currently used for RA?

Do we currently have biomarkers in the setting of RA that will predict patient response to the range of agents — including inhibitors of IL-6, TNF and other signaling cytokines — currently used for RA?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Michael Schiff, MD

Michael Schiff, MD

Clinical Professor of Medicine
Rheumatology Division
University of Colorado School of Medicine
Denver, Colorado
Medical Director
Denver Arthritis Clinic Research Unit